PT  - JOURNAL ARTICLE
AU  - Fuhrmeister, Erica R.
AU  - Harvey, Abigail P.
AU  - Nadimpalli, Maya L.
AU  - Gallandat, Karin
AU  - Ambelu, Argaw
AU  - Arnold, Benjamin F.
AU  - Brown, Joe
AU  - Cumming, Oliver
AU  - Earl, Ashlee M.
AU  - Kang, Gagandeep
AU  - Kariuki, Samuel
AU  - Levy, Karen
AU  - Pinto, Chris
AU  - Swarthout, Jenna M.
AU  - Trueba, Gabriel
AU  - Tsukayama, Pablo
AU  - Worby, Colin J.
AU  - Pickering, Amy J.
TI  - Linking community water and sanitation access to the global burden of antibiotic resistance using human gut metagenomes from 26 countries
AID  - 10.1101/2022.07.01.22277059
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.01.22277059
4099  - http://medrxiv.org/content/early/2022/07/06/2022.07.01.22277059.short
4100  - http://medrxiv.org/content/early/2022/07/06/2022.07.01.22277059.full
AB  - Background Antibiotic resistance is a leading cause of death, with the highest burden in low-resource settings. There is limited evidence on the potential for water, sanitation, and hygiene (WASH) infrastructure to reduce the burden of antibiotic resistance in humans.Methods We used geospatially tagged human gut metagenomes and household survey datasets to determine the association between antibiotic resistance gene (ARG) abundance and community-level coverage of improved drinking water points and improved sanitation facilities. Adjusted general linearized models with robust standard errors were used to estimate the relationship between ARG abundance in the human gut and access to water and sanitation.Findings We identified 1589 publicly available metagenomes from 26 countries. The average abundance of ARGs, in units of log10 ARG reads per kilobase per million (RPKM) mapped reads classified as bacteria, was highest in Africa compared to other World Health Organization (WHO) regions (one-way ANOVA p<0.001, post hoc Tukey HSD p<0.05). Increased access to both improved water and sanitation was associated with lower ARG abundance (effect estimate: -0.26, 95% CI [-0.44, -0.08]); the association was stronger in urban (−0.37 [-0.68, -0.07]) compared to rural areas (–0.16 [-0.38, 0.07]). Improved sanitation alone was associated with reduced ARG abundance (−0.16 [-0.32, 0.00]) while improved drinking water was not (−0.09 [-0.35, 0.16]).Interpretation While additional studies to investigate casual effects are needed, increasing access to water and sanitation could be an effective strategy to curb the proliferation of antibiotic resistance in low- and middle-income countries.Funding Bill & Melinda Gates FoundationEvidence before this study Antibiotic resistance is a growing global health threat that disproportionately affects low- and middle-income countries (LMICs). In 2019, an estimated 5 million deaths were associated with antibiotic resistance, with the highest death rate in western sub-Saharan Africa. Water, sanitation, and hygiene (WASH) interventions (e.g., household drinking water treatment, flush toilet, hand washing facilities with soap) can reduce diarrheal and respiratory infections, as reported in previous meta-analyses. Estimates, based on probability modeling, suggest improvements in water and sanitation could decrease antibiotic use for diarrheal disease treatment by 47-50% and 69-72%, respectively. Improving WASH infrastructure could theoretically contribute to the control of antibiotic resistance by preventing the release of antibiotics, resistant organisms, or antibiotic resistance genes (ARGs) into the environment, thus decreasing the burden of antibiotic-resistant infections. One global analysis across 73 countries suggested that improved infrastructure, including WASH services, was associated with reduced antibiotic resistance prevalence in isolates, however the independent effect of WASH access was not assessed.We searched PubMed for evidence on the impact of WASH interventions (excluding those related to animals and agriculture) on antibiotic resistance using the following keyword chain: (water OR sanitation OR hygiene OR WASH) AND (antimicrobial OR antibiotic) AND resistance) NOT (“OneHealth” OR “One Health” OR animal OR livestock). We selected reviews and systematic reviews (n=1420) to be screened for relevance to WASH and antibiotic resistance. The reference lists of included reviews were then searched for individual studies. We also consulted international agency guidelines and online resources from the Joint Programming Initiative on Antimicrobial Resistance, the International Scientific Forum on Hygiene, ReAct, Resistomap, and the London School of Hygiene and Tropical Medicine AMR Centre.Studies focusing on centralized water or wastewater treatment technologies in high income countries (HICs) reported variable removal of antibiotics (53 to >90%), antibiotic-resistant bacteria (90-99.9%) and ARGs (90-99.9%) from waste streams. Other studies were conducted on hand hygiene, which has proven effective at reducing human infections and antibiotic use. No studies were identified on the effect of on-site sanitation systems (e.g., pour-flush toilets, pit latrines), which serve an estimated 2.7 billion people globally, or fecal sludge management interventions on antibiotic resistance.Added value of this study In this study, we used 1589 publicly available human gut metagenomes from around the world to assess the abundance of ARGs as a function of access to improved drinking water and sanitation infrastructure. This analysis provides new evidence of differences in the abundance of antibiotic resistance in the human gut across the world and finds that decreased gut abundance of ARGs is associated with increased access to improved drinking water and sanitation.Implications of all the available evidence Current approaches to controlling antibiotic resistance in humans predominantly focus on antibiotic stewardship; however, this approach is challenging in LMICs where infectious illnesses are generally more prevalent and unregulated antibiotic usage is common. Along with efforts to provide other known social benefits, such as reducing infectious disease and improving gender equality, improving access to safe drinking water and sanitation could contribute to reducing the burden of antibiotic resistance. This work highlights improving access to adequate water and sanitation as a potentially effective strategy, although additional studies designed to rigorously investigate the casual relationship between WASH and antibiotic resistance are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grant LSHTM INV-006556 from the Bill and Melinda Gates Foundation. ERF was supported by the NSF Postdoctoral Research Fellowships in Biology Program under Grant No. 1906957. MLN was supported by NIH award KL2TR002545 and the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance at Tufts (Levy CIMAR), a collaboration of Tufts Medical Center and the Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP). KL and GT contributions were supported by NIAID grant numbers R01AI137679 and 1K01AI103544. AME and CJW's contributions were supported by NIAID grant number U19AI110818. SK is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI099525 and the Wellcome Trust Grant Number 215675-Z-19-Z. The authors would also like to thank Konstantinos Konstantinidis for his consultation on bioinformatic methods. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the funding organizations.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:At the time of analysis, additional metagenomes from Mozambique, Kenya, and Bangladesh were contributed by authors from this work. The Mozambique study protocol was approved by the Comite Nacional de Bioetica para a Saude (CNBS), Ministerio da Saude (333/CNBS/14), the Ethics Committee of the London School of Tropical Medicine and Hygiene (reference # 8345), and the Institutional Review Board of the Georgia Institute of Technology (protocol # H15160). The associated MapSan trial has been registered at ClinicalTrials.gov (NCT02362932). The Kenya study protocol was approved by the Committee for the Protection of Human Subjects at the University of California, Berkeley (protocol number 2011-09-3654), the institutional review board at Stanford University (IRB-23310), and the scientific and ethics review unit at the Kenya Medical Research Institute (protocol number SSC-2271). The Bangladesh study protocol for the original trial was approved by the International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b) scientific and ethical review committees (protocol number 14022) and the Stanford University human subjects institutional review board (protocol number 30456). All data is now publicly available on the sequence read archives. At the time of analysis all other data were obtained from NCBI's sequence read archives.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll raw sequencing reads are available from the Sequence Read Archives. Data used for analyses are available on open science framework:(https://osf.io/n4z7f/) https://osf.io/n4z7f/